高级检索
当前位置: 首页 > 详情页

Can active surveillance management be developed for patients with low-risk papillary thyroid microcarcinoma? A preliminary investigation in a Chinese population.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming, China. [2]Department of Ultrasound Imaging of The First Affiliated Hospital of Kunming Medical University, Kunming, China.
出处:
ISSN:

摘要:
Active surveillance (AS) has been shown to be a safe approach that can effectively block the transition from overdiagnosis to overtreatment in patients with low-risk papillary thyroid microcarcinoma (PTMC). This study aimed to determine whether the AS approach can be implemented in China and to investigate the population characteristics of Chinese patients who underwent AS.Epidemiological and clinical characteristics and patient adherence were evaluated in 115 patients who underwent AS management as an alternative to immediate surgery for low-risk (or highly suspected) PTMC.The mean patient age was 41.8 (± 10.3) years, with 41.7% and 4.4% of patients < 40 and ≥ 60 years, respectively. The median baseline diameter of the index tumors was 4 (3-6) mm, with 73.0% of tumors being ≤ 5 mm. A total of 84.4% of patients had a junior college, college or graduate degree, and 83.5% were employed in government, public institutions, companies or technical posts. After a median 25-month follow-up, tumor growth ≥ 3 mm occurred in 3 (2.6%) patients, and no new lymph node metastasis occurred. Surgery was performed in 4 patients because of patient preferences rather than disease progression. There was satisfactory adherence in 109 (94.8%) patients in the simulated ideal medical environment.The AS approach can be used as an alternative to low-risk PTMC management in China. Given the difference in epidemiological and clinical characteristics, Chinese institutions should fully consider the features of the Chinese population when developing candidate criteria, surveillance intervals, and follow-up strategies for AS.Copyright © 2022. Published by Elsevier Inc.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2023]版:
大类 | 3 区 医学
小类 | 3 区 内分泌学与代谢
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 内分泌学与代谢
JCR分区:
出版当年[2022]版:
Q2 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q2 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者:
第一作者机构: [1]Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
通讯作者:
通讯机构: [1]Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming, China. [*1]Department of Thyroid Surgery, Clinical Research Center for Thyroid Diseases of Yunnan Province, The First Affiliated Hospital of Kunming Medical University, Kunming, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:52537 今日访问量:0 总访问量:1562 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)